PHARMACEUTICAL BIOLOGY

metrics 2024

Pioneering Research at the Intersection of Biology and Pharmacy

Introduction

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

Metrics 2024

SCIMAGO Journal Rank0.75
Journal Impact Factor3.90
Journal Impact Factor (5 years)4.00
H-Index88
Journal IF Without Self3.90
Eigen Factor0.00
Normal Eigen Factor0.77
Influence0.60
Immediacy Index1.10
Cited Half Life7.60
Citing Half Life5.90
JCI1.33
Total Documents4107
WOS Total Citations9700
SCIMAGO Total Citations21942
SCIMAGO SELF Citations774
Scopus Journal Rank0.75
Cites / Document (2 Years)4.05
Cites / Document (3 Years)4.11
Cites / Document (4 Years)4.27

Metrics History

Rank 2024

Scopus

Complementary and Alternative Medicine in Medicine
Rank #14/105
Percentile 86.67
Quartile Q1
Pharmaceutical Science in Pharmacology, Toxicology and Pharmaceutics
Rank #48/183
Percentile 73.77
Quartile Q2
Pharmacology in Pharmacology, Toxicology and Pharmaceutics
Rank #99/313
Percentile 68.37
Quartile Q2
Drug Discovery in Pharmacology, Toxicology and Pharmaceutics
Rank #55/157
Percentile 64.97
Quartile Q2
Molecular Medicine in Biochemistry, Genetics and Molecular Biology
Rank #72/178
Percentile 59.55
Quartile Q2

IF (Web Of Science)

MEDICAL LABORATORY TECHNOLOGY
Rank 5/30
Percentile 85.00
Quartile Q1
PHARMACOLOGY & PHARMACY
Rank 85/354
Percentile 76.10
Quartile Q1
PLANT SCIENCES
Rank 48/265
Percentile 82.10
Quartile Q1

JCI (Web Of Science)

MEDICAL LABORATORY TECHNOLOGY
Rank 8/30
Percentile 73.33
Quartile Q2
PHARMACOLOGY & PHARMACY
Rank 39/354
Percentile 88.98
Quartile Q1
PLANT SCIENCES
Rank 29/265
Percentile 89.06
Quartile Q1

Quartile History

Similar Journals

Journal of Traditional Chinese Medicine

Bridging Tradition and Innovation in Medicine
Publisher: JOURNAL TRADITIONAL CHINESE MEDISSN: 0255-2922Frequency: 6 issues/year

Journal of Traditional Chinese Medicine, with the ISSN 0255-2922 and E-ISSN 1577-7014, is a distinguished publication dedicated to exploring the rich heritage and contemporary applications of Chinese medicinal practices. Published by JOURNAL TRADITIONAL CHINESE MED in China, this journal contributes significantly to the field of Complementary and Alternative Medicine, holding a respectable Q2 ranking in this category according to the 2023 metrics, and a Q3 ranking in miscellaneous medicine. With its coverage spanning from 1996 to 2024, the journal aims to advance scholarly research and foster an understanding of traditional Chinese healing methodologies, blending ancient wisdom with modern healthcare paradigms. While currently not classified as Open Access, it provides critical insights and detailed analyses that are invaluable for researchers, healthcare professionals, and students interested in the intersection of tradition and innovation in medical practices.

BIOLOGICAL & PHARMACEUTICAL BULLETIN

Advancing the Frontiers of Biomedicine and Drug Development
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0918-6158Frequency: 12 issues/year

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.

CURRENT PHARMACEUTICAL DESIGN

Pioneering Insights in Pharmacology and Drug Development
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1381-6128Frequency: 46 issues/year

CURRENT PHARMACEUTICAL DESIGN is a leading journal in the fields of Drug Discovery and Pharmacology, published by Bentham Science Publishers Ltd in the dynamic United Arab Emirates. With an impressive historical span from 1995 to 2024, this journal serves as a vital platform for disseminating innovative research findings, breakthrough methodologies, and critical reviews that shape the future of pharmaceutical sciences. Ranked Q2 in both Drug Discovery and Pharmacology categories according to the 2023 metrics, it places itself within the top-tier percentile, catering to a diverse audience of researchers, industry professionals, and students. The journal’s commitment to high-quality research exploration is evidenced by its Scopus ranking, where it is positioned favorably within its category ranks. Although currently not Open Access, CURRENT PHARMACEUTICAL DESIGN remains an essential resource for those looking to stay at the forefront of pharmacological advancements and drug development strategies.

Natural Products Journal

Illuminating the Path of Natural Products in Modern Medicine
Publisher: BENTHAM SCIENCE PUBLISSN: 2210-3155Frequency: 4 issues/year

Natural Products Journal, a leading publication by Bentham Science Publishers, primarily focuses on the rapidly evolving field of Natural Products and their applications in Complementary and Alternative Medicine as well as Drug Discovery. With an ISSN of 2210-3155 and an E-ISSN of 2210-3163, this journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the critical role of natural compounds in health and medicine. Since its inception in 2011, it has consolidated its reputation, achieving a Q3 ranking in Complementary and Alternative Medicine and a Q4 ranking in Drug Discovery as of 2023, illustrating its growing influence within the academic community. Although it currently does not operate as an Open Access journal, it remains a vital resource for cutting-edge research and developments in natural products, offering insightful contributions that pave the way for innovative therapeutic strategies. Located in the Netherlands, the journal is pivotal for those looking to stay at the forefront of research in natural substances and their multifaceted applications.

Journal of Natural Medicines

Unlocking the Secrets of Nature for Modern Healing
Publisher: SPRINGER JAPAN KKISSN: 1340-3443Frequency: 4 issues/year

Journal of Natural Medicines, published by SPRINGER JAPAN KK, is a leading academic journal that plays a pivotal role in the advancement of research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, and Pharmaceutical Science. Established in 1994 and set to continue until 2024, this journal serves as a vital conduit for the dissemination of groundbreaking research and innovative ideas that bridge traditional medicinal knowledge and modern scientific inquiry. With its impressive ranking in Scopus—ranking #12 out of 105 in Complementary and Alternative Medicine and holding a Q1 category quartile for 2023—it stands as a reputable source for high-quality, peer-reviewed articles. The journal's commitment to excellence is further underscored by its inclusion in the Springer network, providing researchers, professionals, and students with valuable insights and the latest developments in natural medicines. Although this journal operates under a subscription model, its profound impact on these interdisciplinary fields makes it an essential resource for anyone engaged in the study or practice of natural medicinal therapies.

Current Pharmaceutical Analysis

Catalyzing Discoveries in Biochemistry and Molecular Medicine
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4129Frequency: 6 issues/year

Current Pharmaceutical Analysis, published by Bentham Science Publishers Ltd, is a vital resource for professionals and researchers in the fields of Pharmaceutical Science, Biochemistry, and Molecular Medicine. Established in 2006, this peer-reviewed journal aims to provide a platform for the latest advancements and analytical methodologies in pharmaceutical research and drug development. Over the years, it has garnered attention for its rigorous scrutiny and contributions to the landscape of pharmacology, evidenced by its quartile placements in various categories, most notably Q3 in Pharmaceutical Science. Despite its current rankings placing it in the lower quartile in several disciplines, the journal remains an essential venue for both emerging and established researchers seeking to disseminate their findings. With the widespread accessibility of its articles, researchers, professionals, and students can engage with cutting-edge studies to foster innovation in pharmaceutical analysis. For access to the latest research contributions, readers can explore the digital archive and stay updated on pivotal discussions shaping the future of the pharmaceutical sciences.

Journal of Pharmacy & Pharmacognosy Research

Fostering Collaboration in Pharmacognosy Research
Publisher: JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRESISSN: 0719-4250Frequency: 6 issues/year

Journal of Pharmacy & Pharmacognosy Research, published by JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRES, is a prominent open-access journal established in 2013, headquartered in Antofagasta, Chile. With a focus on the fields of Complementary and Alternative Medicine, Drug Discovery, Pharmaceutical Science, Pharmacology, and Pharmacy, this journal is recognized for its commitment to advancing research and disseminating knowledge within these important areas. With a current impact factor that reflects its academic rigor and relevance, the journal has achieved substantial recognition, evident by its Q2 and Q3 quartile rankings in multiple categories, indicating its growing influence on the scientific community. The Scopus rankings further highlight its standing in pharmacy and pharmacological disciplines, providing a valuable platform for researchers, professionals, and students to share their findings and insights. With its open access model, the journal ensures that high-quality research is available to a global audience, paving the way for collaborative advancements in pharmaceutical sciences.

Chinese Medicine

Unlocking the Potential of Complementary Medicine for Global Health.
Publisher: BMCISSN: 1749-8546Frequency: 1 issue/year

Chinese Medicine is a distinguished open-access journal published by BMC, focusing on the advancement of knowledge and practice in the domain of complementary and alternative medicine. With the ISSN 1749-8546, this journal has established itself as an important resource for researchers, professionals, and students interested in the integration of traditional Chinese medicine with modern scientific practices. Since its inception in 2006, it has garnered a notable reputation, achieving a Q1 ranking in Complementary and Alternative Medicine and Q2 in Pharmacology for 2023, reflecting its high impact and relevance within the academic community. The journal's commitment to disseminating quality research is evident in its Scopus rankings, placing it in the top decile for medicine and pharmacology disciplines. Open access since its launch, Chinese Medicine promotes widespread accessibility and encourages collaborative scholarly efforts in investigating the efficacy and applications of traditional practices in contemporary healthcare. By fostering a platform for rigorous discourse and innovative research, this journal serves as an essential conduit for advancing the understanding of Chinese medicine's role in global health.

Research Journal of Pharmacognosy

Empowering researchers to shape the future of complementary medicine.
Publisher: IRANIAN SOC PHARMACOGNOSYISSN: 2345-4458Frequency: 4 issues/year

Research Journal of Pharmacognosy, published by the Iranian Society of Pharmacognosy, is a pioneering forum for the dissemination of research in the field of pharmacognosy and its related disciplines. Founded in 2014 as an Open Access journal, it aims to provide swift and free access to high-quality research articles, fostering collaboration and innovation among researchers, professionals, and students. Operating from Tehran, Iran, this journal addresses a wide range of topics including complementary and alternative medicine, drug discovery, and organic chemistry, making it an invaluable resource for those researching the extraction, characterization, and application of naturally derived compounds. The journal holds a Category Quartile ranking of Q3 in Complementary and Alternative Medicine and Q4 in both Drug Discovery and Organic Chemistry for the year 2023, which underscores its growing influence within the scientific community. By serving as a platform for current advances and thought leadership in pharmacognosy, the Research Journal of Pharmacognosy plays a crucial role in bridging the gap between traditional practices and modern pharmacological applications.

Advances in Traditional Medicine

Bridging Cultures through Traditional Practices
Publisher: SPRINGERISSN: 2662-4052Frequency: 4 issues/year

Advances in Traditional Medicine, published by SPRINGER, stands at the forefront of the Complementary and Alternative Medicine field, dedicated to exploring the intricate landscapes of traditional medical practices worldwide. With an impressive 2023 Q2 ranking and a Scopus rank of #30/105, this journal is committed to advancing scholarly discourse and innovation in the study and practice of traditional medicine, making it an essential resource for researchers, practitioners, and students alike. As an Open Access journal, it ensures wide accessibility to cutting-edge research and developments from 2020 to 2024, fostering collaboration and knowledge exchange in the global medical community. Based in Singapore, with operations linked to VAN GODEWIJCKSTRAAT 30, 3311 GZ Dordrecht, Netherlands, this journal not only enhances its reach but also enriches the academic landscape with its significant contributions to understanding the role of traditional medicine in contemporary healthcare.